Clinical Trial Update: A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial comparing IBI362 with semaglutide in Chinese adults with early Type 2 diabetes and obesity; the study status is active and not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• IBI362
• semaglutide (semaglutide)

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Type 2 Diabetes, Obesity | Phase 3 | Status: ACTIVE_NOT_RECRUITING